Article Impact Level: HIGH Data Quality: STRONG Summary of Nature https://doi.org/10.1038/s41586-025-10091-1 Dr. Shu Wang et al.
Points
- Researchers developed a magnetic fluid that is guided into the heart via a magnetic field where it solidifies into a stable gel to prevent strokes in atrial fibrillation patients.
- The study found that the magnetogel solidifies within eleven minutes and provides a perfect anatomical fit for complex appendage shapes that traditional metallic devices often struggle to fill and seal.
- Ten month animal trials in pigs showed that the magnetic gel remained completely free of clots and leaks while traditional metal occluders often resulted in rough surfaces and tissue injury.
- The magnetic material successfully resisted high speed blood flow and cardiac contractions during the procedure without showing any evidence of systemic toxicity or inflammatory migration to other major internal organs.
- This innovative approach could offer a long term clinical solution for patients who cannot take blood thinners by ensuring a smooth and firm endocardial lining across all heart appendage morphologies.
Summary
This research evaluated the efficacy of a novel magnetofluid system for personalized left atrial appendage occlusion (LAAO) to overcome the limitations of traditional metallic devices. Standard occluders often result in peri-device leaks and device-related thrombus due to the morphological variability of the appendage. The proposed system utilizes a magnetic fluid composed of neodymium-iron-boron particles and poly(vinyl alcohol) that is guided via a 50 to 200 mT magnetic field. Upon contact with blood water, the fluid undergoes liquid-liquid phase separation, initiating solidification within 60 seconds and reaching stable gelation in approximately 11 minutes.
In vivo longitudinal studies in porcine models demonstrated the long-term resilience and biocompatibility of the magnetogel over a 10-month period. Comparative analysis against the Watchman occluder revealed that the magnetogel provided complete anatomical filling without the myocardial injury associated with anchoring barbs. While the Watchman group exhibited rough, incomplete endocardial coverage and surface thrombi, the magnetogel group achieved a smooth, thrombus-free endocardial lining with no observable crevices or leaks. Cyclic compression tests further confirmed the structural integrity of the gel, with the risk of dislodgement effectively eliminated once the ostium was sealed by the collagen network after 7 days.
The findings suggest that magnetofluids offer a promising clinical solution for achieving total occlusion across all appendage morphologies, including challenging windsock and cauliflower types. The material effectively resisted high-speed blood flow and cardiac contractions under magnetic guidance, with no evidence of systemic toxicity or particle migration in rat or pig models. Although the presence of magnetic particles creates significant artifacts on cardiac MRI, the substantial reduction in postoperative stroke risk and device-related complications suggests this approach could revolutionize long-term thrombus-free LAAO for patients ineligible for systemic anticoagulation.
Link to the article: https://www.nature.com/articles/s41586-025-10091-1
References
Wang, S., Ju, W., Zhuang, D., Chen, Z., Zhao, D., Huang, S., Wang, T., Cai, M., Liu, S., Fu, S., Cheng, Z., Tan, W., Pan, X., Wu, X., Wang, S., & Xu, T. (2026). Long-term thrombus-free left atrial appendage occlusion via magnetofluids. Nature, 651(8104), 91–99. https://doi.org/10.1038/s41586-025-10091-1
